Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Elixinol Wellness ( (AU:EXL) ).
Elixinol Wellness Limited has announced significant executive leadership changes, appointing Natalie Butler as the new Chief Executive Officer and Adam Dimitropoulos as the Chief Financial Officer. These appointments are aimed at strengthening the company’s leadership team and positioning it for growth. Natalie Butler, who has been instrumental in leading the company through a complex period, is expected to drive the next phase of the company’s strategic priorities. Adam Dimitropoulos brings extensive financial and operational expertise, which will support Elixinol’s focus on delivering sustained profitability. The company acknowledges the contributions of outgoing CFO Josephine Lorenz and wishes her well in her future endeavors.
More about Elixinol Wellness
Elixinol Wellness Limited is a prominent player in the global hemp industry, focusing on the innovation, marketing, and sale of hemp and other plant-derived food, skincare, and nutraceutical products. In Australia, the company operates a vertically integrated business across four verticals: human nutrition, human wellness, pet wellness, and superfood ingredients, with products distributed through grocery, wholesale, and e-commerce channels. Elixinol USA offers high-quality branded hemp and plant-derived nutraceutical and skincare products.
YTD Price Performance: -65.79%
Average Trading Volume: 389,310
Technical Sentiment Signal: Sell
Current Market Cap: A$3.44M
Find detailed analytics on EXL stock on TipRanks’ Stock Analysis page.